Publication October 23, 2026

New Publication Compares Etelcalcetide and Cinacalcet in Hemodialysis Study

A new publication involving etelcalcetide was released on October 23, 2026. The study, titled "Comparative Effectiveness and Safety of Etelcalcetide and Cinacalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Multicenter Retrospective Cohort Study," appeared in the Journal of Clinical Medicine. It is described as a multicenter retrospective cohort study. The research focuses on hemodialysis patients with secondary hyperparathyroidism. The title indicates a comparison between etelcalcetide and cinacalcet regarding effectiveness and safety in this patient population. No specific findings, results, or outcome data from the study have been provided. Readers interested in the details of the comparative analysis should consult the full publication directly through the journal. Etelcalcetide remains an approved compound. This entry reflects only the existence and bibliographic details of the publication as recorded. For more background on etelcalcetide, including its approved uses and general profile, readers can consult the compound overview.

See the full etelcalcetide overview

Source: https://pubmed.ncbi.nlm.nih.gov/43030414/